Aldebaran Capital, LLC
CARMEL, IN · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$139.1M2026 Q3
Positions43
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.60.2%
What Changed This Quarter?
Top Holdings
BRK-B
Berkshire Hathaway
15.0%
LLY
Eli Lilly
7.5%
MSFT
Microsoft
7.5%
BG
Bunge Global
5.1%
SU
Suncor Energy
5.0%
IWS
Ishares Tr Rus
4.7%
AMLX
Amylyx Pharmaceuticals
4.1%
BAC
Bank of America
4.0%
New / Increased
4 new · 13 increased
ENGNNEW
Engene Therapeutics
0.9%
PLRXNEW
Pliant Therapeutics
0.3%
OXY-WSNEW
Occidental Petroleum
0.2%
EXMOCNEW
Exxon Mobil
0.1%
LKQ
LKQ
3.5%
+34.9%
CATO
Cato
2.4%
+19.5%
IWS
Ishares Tr Rus
4.7%
+3.0%
BRK-B
Berkshire Hathaway
15.0%
+0.8%
Reduced / Exited
16 reduced · 0 sold out
OXY
Occidental Petroleum
3.0%
-43.4%
RELL
Richardson Electrs
1.0%
-15.7%
SIRI
Sirius XM
2.1%
-1.1%
CVX
Chevron
3.8%
-0.4%
BG
Bunge
5.1%
-0.2%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.